Onconephrology
Symposium 2026
An advanced two-day program at the intersection of kidney disease,
cancer, hematologic disorders and modern cancer therapeutics.
2 DAYS
SEPT 17–18, 2026
VIDEOS + SLIDES
Where Cancer Care
Meets Kidney Medicine
The Harvard Onconephrology Symposium 2026
focuses on one of the most complex intersections in contemporary medicine:
the management of kidney disease in patients with cancer and hematologic disorders.
Modern cancer therapies have transformed oncology, but they also create new
diagnostic and therapeutic challenges for nephrologists and multidisciplinary
cancer teams.
This symposium explores these challenges through expert lectures, clinical
discussions and case-focused sessions spanning kidney injury, glomerular disease,
monoclonal disorders, transplantation, chemotherapy nephrotoxicity,
immunotherapy and emerging cancer treatments.
A Multidisciplinary Approach
NEPHROLOGY
Kidney injury, glomerular disease, GFR, transplantation and renal protection.
ONCOLOGY
Cancer therapies, treatment-related toxicity and multidisciplinary patient care.
HEMATOLOGY
Plasma-cell disorders, monoclonal gammopathies, amyloidosis and light-chain disease.
CANCER THERAPEUTICS
Chemotherapy, immunotherapy, cellular therapies and targeted treatments.
Onconephrology Symposium 2026
September 17–18, 2026
2 Days
Videos + Slides
Nephrology • Oncology & Hematology • Pharmacology
2026
What You’ll Learn
Build a broader understanding of renal complications associated with cancer
and contemporary cancer treatment.
Diagnosis and management of renal complications in patients with cancer.
Explore cancer-associated glomerular disorders and evolving treatment considerations.
Review evolving diagnostic and therapeutic concepts in TMA.
Examine MGRS, immunoglobulin-mediated injury, amyloidosis and plasma-cell disease.
Understand renal toxicity associated with chemotherapy and emerging therapies.
Explore CAR-T, immune checkpoint inhibitors and other modern treatment approaches.
Review complex transplant considerations in patients with malignancy.
Consider strategies for protecting kidney function during cancer treatment.
The Clinical Decision Path
Identify the Cancer Context
Understand the malignancy, hematologic disorder and current therapeutic strategy.
Evaluate Kidney Function
Assess AKI, GFR, proteinuria, glomerular disease and other renal abnormalities.
Determine the Potential Mechanism
Consider malignancy-associated disease, drug toxicity, immune injury and monoclonal processes.
Balance Cancer Therapy & Renal Risk
Evaluate treatment continuation, modification, rechallenge and kidney-protective strategies.
Coordinate Multidisciplinary Care
Integrate nephrology, oncology, hematology, transplantation and supportive care.
September 18, 2026
Amyloidosis • Plasma-Cell Disorders • MGRS • Transplantation • Light-Chain Disease
Vaishali Sanchorawala
Anju Nohria
Nikhil Munshi
Samih H. Nasr
Christophe Sirac
The Onconephrology Jeopardy Challenge
Shruti Gupta • Kenar Jhaveri
Jorge J. Castillo
Nelson Leung
Christopher Blosser • Raad Chowdhury
Christopher Blosser
The War Against Light Chains
Raad Chowdhury • Sujal Shah • Nelson Leung • Kenar Jhaveri
The Onconephrology Landscape
Program Leadership
Raad Chowdhury, MD, FASN
Course Director
Medical Director of Onconephrology, Brigham and Women’s/Dana-Farber Cancer Institute
APD, Mass General Brigham Nephrology Fellowship, Harvard Medical School
Shruti Gupta, MD, MPH
Course Director
Director of Onconephrology, Brigham and Women’s/Dana-Farber Cancer Institute
Assistant Professor, Harvard Medical School
Designed for Multidisciplinary Cancer & Kidney Care
Particularly relevant for healthcare professionals involved in the care
of patients with malignancy and renal complications.
Modern Cancer Therapy Creates
New Kidney Challenges
As cancer treatment evolves, clinicians increasingly encounter renal complications
associated with chemotherapy, immunotherapy, cellular therapy, monoclonal disorders
and complex hematologic disease.
Effective management often requires balancing cancer control with preservation
of kidney function while navigating diagnostic uncertainty, drug dosing,
treatment toxicity and multidisciplinary decision-making.
Understand the Kidney.
Navigate Cancer Therapy.
Manage the Intersection.
An advanced two-day educational program exploring kidney injury,
cancer therapeutics, glomerular disease, monoclonal disorders,
transplantation and multidisciplinary onconephrology care.
Reviews
There are no reviews yet.